{
    "code": "52026537",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026537",
    "time": "2020-03-20 05:12:24",
    "許可證字號": "衛部藥輸字第026537號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "109\/05\/04",
    "發證日期": "104\/05\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202653706",
    "中文品名": "可艾妥搏穩膜衣錠300毫克\/25毫克",
    "英文品名": "Co-Alvoprel 300mg\/25mg film-coated tablets",
    "適應症": "本態性高血壓。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000粒 盒裝PVC-PE-PVDC 鋁箔塑料罩包裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE), IRBESARTAN",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGR0039000  GENEPHARM S.A",
            "製造廠廠址": "18 km Marathon Avenue, 15351 Pallini-Greece\/ Greece",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4028100600",
            "成分名稱": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200038400",
            "成分名稱": "IRBESARTAN",
            "含量描述": "",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "藥物外觀_irbesartanHCTZ_(300-25)mg-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026537&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Annex 2. Irbesartan HCT propose PIL_final-109-01-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026537&Seq=005&Type=9"
        },
        {
            "title": "Foil_7726_Round_2-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026537&Seq=005&Type=8"
        },
        {
            "title": "Carton_7725_Round_3-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026537&Seq=004&Type=8"
        },
        {
            "title": "52026537-3-104-06-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026537&Seq=003&Type=8"
        }
    ]
}